M&A Deal Summary |
|
---|---|
Date | 2014-02-18 |
Target | Forest Laboratories |
Sector | Medical Products |
Buyer(s) | Allergan |
Deal Type | Add-on Acquisition |
Deal Value | 25.0B USD |
Advisor(s) | J.P. Morgan Securities (Financial) Wachtell, Lipton, Rosen & Katz (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1956 |
Sector | Life Science |
Employees | 31,200 |
Revenue | 15.8B USD (2018) |
Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.
DEAL STATS | # |
---|---|
Overall | 14 of 38 |
Sector (Medical Products) | 3 of 11 |
Type (Add-on Acquisition) | 11 of 31 |
State (New York) | 1 of 2 |
Country (United States) | 8 of 27 |
Year (2014) | 1 of 5 |
Size (of disclosed) | 2 of 25 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-08-06 |
Palau Pharma - Albaconazole Antifungal Agent
United States Palau Pharma - Albaconazole Antifungal Agent an oral antifungal agent for the treatment of vulvo-vaginal candidiasis, onychomycosis and other antifungal applications. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-04-01 |
Silommedical
Bangkok, Thailand Silommedical Co., Ltd. is a privately held generic pharmaceutical company focused on developing and marketing therapies in Thailand |
Buy | $100M |